Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1

Abstract

Comprehensive profiling of a large cohort of this rare subtype of breast carcinoma highlighted the predominance of <i>TP53</i> mutation and increased PD-L1 expression in carcinoma cells. These results can be exploited in clinical trials using immune checkpoint inhibitors.